US · Healthcare · Biotechnology
EPS came in at -0.31 against a street estimate of -0.27 — a miss of 14.8%.
Analysts rate Seer Inc a buy (1 buy, 2 hold, 0 sell out of 3) with an average price target of $4.00.
| Fund | Stake |
|---|---|
| SoftBank Group Corp | 9.27% |
| Siren, L.L.C. | 4.44% |
| Acadian Asset Management LLC | 3.75% |
| Vanguard Capital Management, LLC | 3.54% |
| BlackRock Inc | 3.29% |
| Renaissance Technologies Corp | 1.76% |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 1.49% |
| AJU IB Investment Co Ltd | 1.47% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Seer Inc — free to start.
Google PlayApp StoreData updated 2026-09-18.